TRVI

Conviction 80HealthcareScan · Mon, Aug 10, 2026

TRVI$17.79-3.89%

ResistanceSupportVol 14

Vol MA14 1.73M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Trevi Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.trevitherapeutics.com ↗

Price17.79

Change-3.89%

Gap+0.59%

Rel volume0.71×

Avg volume2.27M

Avg $ vol41.11M

SMA 2018.05

SMA 5016.91

SMA 20013.39

Price vs 50+5.22%

Price vs 200+32.83%

MA stackbullish

50/200 cross—

Supertrendup · 16.28

RSI (14)50

MACD hist-0.07

MACD cross—

Stoch %K / %D37 / 57

ADX (14)31

+DI / −DI22 / 13

RSI divergence—

MACD divergence—

ATR %+5.87%

ADR %6.35%

52w high19.50

52w low7.01

From 52w high-8.77%

Above 52w low+153.78%

New 52w highNo

SqueezeOn · 7d

Bollinger width12.51%

%B0.39

Donchian pos38.94%

Donchian high20.22

Donchian low16.24

AVWAP (52w high)18.21

vs AVWAP high-2.31%

AVWAP (52w low)12.64

vs AVWAP low+40.70%

OBV trendUp

Chaikin MF (20)0.12

Today vs 20d0.71×

Avg vol (14d)1.73M

Avg vol (20d)2.27M

Avg $ vol (20d)41.11M

Market cap2.53B

RS 3m (vs SPY)+26.05%

RS 6m (vs SPY)+55.08%

RS line new highNo

Trend template8/8

Technical rank81.0

1 week-0.61%

1 month-0.28%

3 months+22.69%

6 months+55.24%

1 year+143.70%

YTD+49.62%

P/E-59.28

P/B7.88

P/S—

P/FCF-60.20

EPS-0.3200

Div yield—

ROE-13.30%

ROA-12.94%

Debt/Eq—

Current37.28

EV/EBITDA-50.43

Gross margin—

Net margin—

Rev growth—

EPS growth10.75%

Price target29.11

Target upside63.63%

Analyst ratingBuy

Institutional101.41%

Ent. value2.48B

Revenue—

Net income-17.8M

Gross profit—

Free cash flow-42.1M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out141.98M

Employees34

ListedFri, May 3, 2019

Free float118.27M

Float %83.3%

Short interest12.65M

Days to cover4.8d

Short volume60.6%

Squeeze score59 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.11 vs −$0.11

Last surprise0.0% beat

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank81.0 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance20.19

Support16.43

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TRVI

All disclosures →

No recent disclosed trades by Congress in TRVI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TRVI · 5 buys

Insider	Side	Shares	Value	Traded	Filed
Meeker David P Director · Nonstatutory Stock Option (right to buy) · 2026-06-03	Grant	35K	$0	2026-06-03	2026-06-04
Mathers Edward T Director · Nonstatutory Stock Option (right to buy) · 2026-06-03	Grant	35K	$0	2026-06-03	2026-06-04
Colangelo Dominick Director · Nonstatutory Stock Option (right to buy) · 2026-06-03	Grant	35K	$0	2026-06-03	2026-06-04
VANLENT ANNE Director · Nonstatutory Stock Option (right to buy) · 2026-06-03	Grant	35K	$0	2026-06-03	2026-06-04
Heffernan Michael Thomas Director · Nonstatutory Stock Option (right to buy) · 2026-06-03	Grant	35K	$0	2026-06-03	2026-06-04

SEC filings

EDGAR filings in TRVI · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.